Inc: DKT WomanCare : and Incepta Pharmaceuticals Ink Strategic Deal to Expand Markets, Scale Up Access to World-Class Injectable Contraceptive in 40 Countries

(marketscreener.com) WomanCare Global Trading CIC and Incepta Pharmaceuticals, Ltd. signed a strategic agreement on July 1, 2020 to register, supply, promote and sell Medogen® in 40 countries around the world. Medogen® is a 3-month contraceptive commonly known as depot medroxyprogesterone acetate, or DMPA-IM. This agreement leverages the capabilities of...https://www.marketscreener.com/news/latest/DKT-WomanCare-and-Incepta-Pharmaceuticals-Ink-Strategic-Deal-to-Expand-Markets-Scale-Up-Access-to--31291629/?utm_medium=RSS&utm_content=20200914